Concourse Financial Group Securities, Inc. Lava Therapeutics Nv Call Options Transaction History
Concourse Financial Group Securities, Inc.
- $1.56 Billion
- Q2 2024
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding LVTX
# of Institutions
26Shares Held
3.76MCall Options Held
85.8KPut Options Held
36.8K-
Redmile Group, LLC San Francisco, CA2.07MShares$3.57 Million0.24% of portfolio
-
Bruce & Co., Inc. Chicago, IL772KShares$1.33 Million0.68% of portfolio
-
Sphera Funds Management Ltd. Tel Aviv, L3368KShares$632,2410.1% of portfolio
-
Two Sigma Investments, LP New York, NY112KShares$193,3950.0% of portfolio
-
Alpha Wave Global, LP New York, NY87.4KShares$150,3220.08% of portfolio
About LAVA Therapeutics NV
- Ticker LVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,797,700
- Market Cap $44.4M
- Description
- LAVA Therapeutics N.V., a clinical-stage immuno-oncology company, focuses on developing cancer treatments. The company, through its Gammabody platform, develops a portfolio of novel bispecific antibodies to engage and leverage the potency and precision of gamma delta T cells to elicit an anti-tumor immune response and enhance outcomes for cancer...